 hmg-coa reductas inhibitor-induc myopathi rat cyclosporin interact mechan studi recent clinic evid potenti skelet muscl toxic therapi hmg-coa reductas inhibitor hmgri man incid drug-induc skelet muscl toxic low monotherapi concomit drug therapi immunosuppress csa certain hypolipidem agent sprague-dawley rat high compar dosag mg/kg/day similar hmgri lovastatin simvastatin pravastatin dose-rel increas incid sever skelet muscl degener physic sign inappet decreas activ loss bodi weight alopecia mortal interact hmgri csa rat model csa-induc cholestasi model skelet muscl toxic hmgri csa mg/kg/day dose hmgri skelet muscl toxic incid myopathi skelet muscl degener csa typic light microscop chang myofib necrosi interstiti edema inflammatori infiltr area acut injuri histochem character muscl lesion type fiber glycolyt white fiber sensit toxic prolong administr type result pharmacokinet studi rat variou hmgri csa coadministr csa disposit compound system exposur increas area plasma drug concentr time curve-auc consequ skelet muscl drug level evalu potenti interact hmgri lovastatin csa level hepat microsom metabol csa metabol lovastatin isol microsom femal rat light find hmgri-induc myopathi class effect rat csa result alter clearanc result tissu exposur cholestasi csa hmgri basi decreas elimin result system exposur toxic fiber-select impair skelet muscl energi metabol